Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has ignited significant market reactions.
On the day following the report, MSOS ETF (NYSE:MSOS) surged 21%. Notable companies also experienced remarkable gains, with State House Holdings Inc. (OTC:STHZF) skyrocketing by 74%, Columbia Care (OTC:CCHWF) witnessing a 38% boost, Jushi (OTC:JUSH) rising by 32% and Ayr Wellness (OTC:AYRWF) showing a 29% increase.
Analysis firm Zuanic & Associates (Z&A), in a recent report, says the news is a potentially game-changing development.
Delve Deeper into...
Login or create a forever free account to read this news
Sign up/Log in